News | July 21, 2023
Tillotts Pharma and TVM Capital form Mage Biologics to develop oral antibody therapy for ulcerative colitis
Mage Biologics to develop a monoclonal antibody targeting ulcerative colitis
Mage Biologics to develop a monoclonal antibody targeting ulcerative colitis
The agreement extends the customer's suite of cloud DevOps, data engineering, and data platform management solutions
Moist wound dressing for chronic wound treatment now available in Germany
Evonik specializes in mid- to large-scale, later clinical phase HPAPIs
Advances clinical research capabilities with leading regulatory grade registries platform
Cytel excels at using proven quantitative techniques to transform real-world data into actionable insights
This four-day course is designed for professionals in the pharmaceutical, nutraceutical, and related industries
Pratima takes on the role of Country Speaker in addition to her role as GM and MD of Merck Specialties in India
The €70 million investment will allow the large-scale manufacturing of high-purity reagents for quality control and testing for biopharma customers, increasing annual output by several thousand tons
Mix-n-Stain CF Dye IgM Antibody Labeling Kits address longstanding challenges for labeling IgM antibodies by offering efficient and convenient conjugation with bright CF Dyes
Subscribe To Our Newsletter & Stay Updated
